Sugi Predict

Sugi Predict / Compounds / SCHEMBL4448294

SCHEMBL4448294

SCHEMBL4448294

CC(=O)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ HSD17B1 P14061 2/20 0.64
▸ MAPT P10636 2/20 0.64
▸ BCL2L1 Q07817 1/20 0.64
▸ BAD Q92934 1/20 0.64
▸ PTGS1 P23219 1/20 0.61
▸ KIF11 P52732 1/20 0.55
▸ MAOB P27338 1/20 0.55
▸ CES2 O00748 1/20 0.54
▸ CES1 P23141 1/20 0.54
▸ PTPN1 P18031 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.50
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ ALOX5 P09917 1/20 0.50
▸ XDH P47989 1/20 0.48
▸ HPGD P15428 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL54677 0.93 CES2 (0.62) SMN1; SMN2HSD17B1MAPTBCL2L1BAD
SCHEMBL1696183 0.93 CES2 (0.62) SMN1; SMN2HSD17B1MAPTBCL2L1BAD
Hydrochloric Acid SCHEMBL27523727 0.90 CES2 (0.59) SMN1; SMN2HSD17B1MAPTBCL2L1BAD
Hydrogen Sulfide SCHEMBL9392620 0.90 MAPT (0.77) SMN1; SMN2HSD17B1MAPTBCL2L1BAD
Acetic Acid SCHEMBL28372390 0.88 CES2 (0.56) SMN1; SMN2HSD17B1MAPTBCL2L1BAD
SCHEMBL11441494 0.87 MAPT (0.80) SMN1; SMN2HSD17B1MAPTKIF11ALDH1A1
SCHEMBL197130 0.87 MAPT (0.80) SMN1; SMN2HSD17B1MAPTKIF11ALDH1A1
Boric Acid SCHEMBL29051484 0.86 MAOB (0.55) SMN1; SMN2HSD17B1MAPTBCL2L1BAD
SCHEMBL7937485 0.86 LTA4H (0.59) SMN1; SMN2MAPTPTGS1MAOBCES2
Water SCHEMBL9631932 0.85 HSD17B1 (0.76) SMN1; SMN2HSD17B1MAPTKIF11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119998272-A Methanogen inhibitors 阿格里泽伦茨有限合伙公司 2025-05-13 — — CN disclosed
US-12030875-B2 EIF4E inhibitors and uses thereof PIC Therapeutics, Inc. (US) 2024-07-09 — — US disclosed
WO-2024039250-A1 METHANOGEN INHIBITORS PASTORAL GREENHOUSE GAS RESEARCH LIMITED (NZ) 2024-02-22 — — WO disclosed
EP-3846793-B1 EIF4E INHIBITORS AND USES THEREOF PIC THERAPEUTICS INC (US) 2024-01-24 — — EP disclosed
EP-3846793-B1 EIF4E INHIBITORS AND USES THEREOF PIC THERAPEUTICS INC (US) 2024-01-24 — — EP disclosed
CN-111170991-B Antiproliferative compounds and methods of synthesis thereof 细胞基因公司 2023-10-31 — — CN disclosed
EP-3594211-B1 ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF CELGENE CORP (US) 2023-10-25 — — EP disclosed
US-20230303543-A1 NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2023-09-28 — — US disclosed
US-20230303543-A1 NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2023-09-28 — — US disclosed
US-20220387413-A1 ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF CELGENE CORP (US) 2022-12-08 — — US disclosed
US-4115456-A Alkyne compounds and method of use MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-19 — — US disclosed
US-4110447-A Anti-inflammatory (halo-4-biphenylyl)-alkanolamines MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1978-08-29 — — US disclosed
US-4100300-A ANTIINFLAMMATORY, TRANQUILIZER SANDOZ, INC. (US) 1978-07-11 — — US disclosed
US-4096338-A ANTIPHLOGISTIC NISSHIN FLOUR MILLING CO., LTD. (JA) 1978-06-20 — — US disclosed
US-4060633-A Phenylalkanol nitriles MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1977-11-29 — — US disclosed
US-4042617-A FROM A GLYCIDIC ACID ESTER NISSHIN FLOUR MILLING CO., LTD. (JA) 1977-08-16 — — US disclosed
US-4032580-A ANTI-INFLAMMATORY 1-PHENYL-2,3-BUTADIEN-1-OLS, METHODS OF USE AND COMPOSITIONS CONTAINING SAME SANDOZ, INC. (US) 1977-06-28 — — US disclosed
US-4016196-A HEATING GLYCIDIC ESTERS NISSHIN FLOUR MILLING CO., LTD. (JA) 1977-04-05 — — US disclosed
US-4007217-A FROM A GLYCIDATE NISSHIN FLOUR MILLING CO., LTD. (JA) 1977-02-08 — — US disclosed
US-3980795-A Pyrazolidinones and a process for their preparation MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1976-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220387413-A1 ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF MCL1, MKI67, BAX SMN1; SMN2 289/4885HSD17B1 2919/4885MAPT 4744/4885
US-12030875-B2 EIF4E inhibitors and uses thereof EIF4E, EIF4EBP1, EIF4A1 SMN1; SMN2 1052/4885HSD17B1 4514/4885MAPT 2395/4885
US-20230303543-A1 NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF LDHA, SDHA, LDHB SMN1; SMN2 1819/4885HSD17B1 158/4885MAPT 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.